InvestorsHub Logo
Followers 32
Posts 1367
Boards Moderated 0
Alias Born 10/01/2012

Re: Trevor11 post# 9367

Friday, 05/08/2015 11:14:46 AM

Friday, May 08, 2015 11:14:46 AM

Post# of 10371
Folks it is looking like we just bounce around 3.00 to 2.25 area until we get some definitive news on success of casino games?

Anyone suspecting ZNGA is sitting up to go into actual online paid (money) casino gambling, down the road in 2016-2017? It would not be much of a stretch to expand 'social casino' into
something individual USA states could contract for, as way to increase tax revenue.

The old guard in bricks-and-mortar casinos is facing a real challenge from mobile gaming play. However; powerful they are in places like NV they still cannot fight the huge monies that Amazon and Goggle have. The other 'problem' is politically, no one is really interested in re-starting domestic USA. The Internationalists and Mega-corps. and top 5% are doing just fine.
Within in such a challenging jobs and tax environment domestically, the physical casino gambling model is suffering a loss of MC and LC spending visitors. Stay-Kations (relaxing at home) or on the street scene, is becoming the new virtual source of thrill.
And, mobile gaming plays right into it.

I have this vision that ZNGA 'gets it' . . . and if they can display good social casino game execution by 2015 winter . . . partners and buy-out possibilities will b an additional stock price support for ZNGA.

I am thinking ZNGA, has chose to license slot VG material as a way to more quickly accelerate their time table of launch, and that they have secured the right to modify those lic VGs.
I also am pondering the notion that ZNGA will be active after E3 in making some new acquisition/partnering. My perception is we are viewing quit soon a consolidation of small VG companies, and ZNGA can trade (maybe) shares and some front money, to in-effective garner the spoils, so to speak?

The new model of business is to lease services and talent.
Note how effective the large Pharmas are in seeking partnerships with small biotechs (cheaper, faster and 'the egg-on-face' falls away from the larger company mmgt)?